{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T12:23:23Z","timestamp":1759580603795,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T00:00:00Z","timestamp":1595635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T00:00:00Z","timestamp":1595635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ultrasound"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aims<\/jats:title>\n                <jats:p>Not all obstructive hypertrophic cardiomyopathy (HCM) patients are symptomatic. The relation between obstructive HCM and symptoms is not well understood. The hypothesis of this study is that left-ventricular outflow tract (LVOT) acceleration time (AT) is associated with symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We included 187 patients (61% men, mean age 55\u2009\u00b1\u200914\u00a0years) with obstructive HCM, defined as a maximal wall thickness\u2009\u2265\u200915\u00a0mm and a resting or provoked LVOT peak gradient\u2009\u2265\u200930\u00a0mmHg. Peak velocity (PV), left-ventricular (LV) ejection time (ET), and AT (the time between LVOT flow onset and the moment of PV) were measured on continuous-wave (CW) Doppler tracings. Logistic and Cox proportional hazard regression analyses were used to evaluate the relation between symptoms [New York Heart Association (NYHA) class\u2009\u2265\u2009II] and echocardiographic measurements, including AT. Reproducibility was assessed using the intraclass correlation coefficient (ICC).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Symptomatic patients were more often female and had higher mean AT values. Logistic regression demonstrated a significant association between AT and symptomatic status (odds ratio 1.31 per 10\u00a0ms, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01) after adjustment for sex, negative inotropes, PV, LVOT diameter, and diastolic dysfunction. AT was independently associated with symptoms and septal reduction during follow-up (hazard ratio 1.09 per 10\u00a0ms, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). The ICC was 0.98 with a mean difference of 0.28\u2009\u00b1\u20098.4\u00a0ms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In obstructive HCM patients, increased AT is significantly related to symptoms after adjustment for sex, negative inotropes, PV, LVOT diameter, and diastolic dysfunction, and is associated with the symptomatic status during follow-up. AT represents an easily measured echocardiographic variable with excellent inter-reader reproducibility.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s40477-020-00513-3","type":"journal-article","created":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T09:03:37Z","timestamp":1595667817000},"page":"279-287","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Left-ventricular outflow tract acceleration time is associated with symptoms in patients with obstructive hypertrophic cardiomyopathy"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7405-8668","authenticated-orcid":false,"given":"Roy","family":"Huurman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Michels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjon A.","family":"van Slegtenhorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arend F. L.","family":"Schinkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,25]]},"reference":[{"issue":"12","key":"513_CR1","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","volume":"65","author":"C Semsarian","year":"2015","unstructured":"Semsarian C, Ingles J, Maron MS, Maron BJ (2015) New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol 65(12):1249\u20131254","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"513_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1056\/NEJMoa021332","volume":"348","author":"MS Maron","year":"2003","unstructured":"Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, Cecchi F, Maron BJ (2003) Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 348(4):295\u2013303","journal-title":"N Engl J Med"},{"issue":"21","key":"513_CR3","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","volume":"114","author":"MS Maron","year":"2006","unstructured":"Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, Nistri S, Cecchi F, Udelson JE, Maron BJ (2006) Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114(21):2232\u20132239","journal-title":"Circulation"},{"issue":"3","key":"513_CR4","doi-asserted-by":"publisher","first-page":"e443","DOI":"10.1016\/j.ijcard.2013.12.318","volume":"172","author":"SH Kim","year":"2014","unstructured":"Kim SH, Kim JS, Kim BS, Choi J, Lee S-C, Oh JK, Park SW (2014) Time to peak velocity of aortic flow is useful in predicting severe aortic stenosis. Int J Cardiol 172(3):e443\u2013e446. https:\/\/doi.org\/10.1016\/j.ijcard.2013.12.318","journal-title":"Int J Cardiol"},{"issue":"10","key":"513_CR5","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.echo.2017.06.001","volume":"30","author":"S Gamaza-Chulian","year":"2017","unstructured":"Gamaza-Chulian S, Diaz-Retamino E, Camacho-Freire S, Ruiz-Fernandez D, Gutierrez-Barrios A, Oneto-Otero J (2017) Acceleration time and ratio of acceleration time to ejection time in aortic stenosis: new echocardiographic diagnostic parameters. J Am Soc Echocardiogr 30(10):947\u2013955","journal-title":"J Am Soc Echocardiogr"},{"issue":"12","key":"513_CR6","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1111\/echo.12978","volume":"32","author":"S Gamaza-Chulian","year":"2015","unstructured":"Gamaza-Chulian S, Camacho-Freire S, Toro-Cebada R, Giraldez-Valpuesta A, Benezet-Mazuecos J, Vargas-Machuca JC (2015) Ratio of acceleration time to ejection time for assessing aortic stenosis severity. Echocardiography 32(12):1754\u20131761","journal-title":"Echocardiography"},{"issue":"10","key":"513_CR7","doi-asserted-by":"publisher","first-page":"e003907","DOI":"10.1161\/JAHA.116.003907","volume":"5","author":"D Kamimura","year":"2016","unstructured":"Kamimura D, Hans S, Suzuki T, Fox ER, Hall ME, Musani SK, McMullan MR, Little WC (2016) Delayed time to peak velocity is useful for detecting severe aortic stenosis. J Am Heart Assoc 5(10):e003907. https:\/\/doi.org\/10.1161\/JAHA.116.003907","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"513_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s40477-019-00373-6","volume":"22","author":"HE Sumbul","year":"2019","unstructured":"Sumbul HE, Koc AS, Demirtas D, Koca H, Pekoz BC, Gorgulu FF, Donmez Y, Demirtas AO, Koc M, Icen YK (2019) Increased renal cortical stiffness obtained by share-wave elastography imaging significantly predicts the contrast-induced nephropathy in patients with preserved renal function. J Ultrasound 22(2):185\u2013191","journal-title":"J Ultrasound"},{"issue":"2","key":"513_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jus.2008.03.006","volume":"11","author":"M Meola","year":"2008","unstructured":"Meola M, Petrucci I (2008) Color Doppler sonography in the study of chronic ischemic nephropathy. J Ultrasound 11(2):55\u201373","journal-title":"J Ultrasound"},{"issue":"39","key":"513_CR10","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","volume":"35","author":"PM Elliott","year":"2014","unstructured":"Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H (2014) 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European society of cardiology (ESC). Eur Heart J 35(39):2733\u20132779","journal-title":"Eur Heart J"},{"issue":"11","key":"513_CR11","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/j.amjcard.2018.08.040","volume":"122","author":"HG van Velzen","year":"2018","unstructured":"van Velzen HG, Schinkel AFL, Baart SJ, Huurman R, van Slegtenhorst MA, Kardys I, Michels M (2018) Effect of gender and genetic mutations on outcomes in patients with hypertrophic cardiomyopathy. Am J Cardiol 122(11):1947\u20131954","journal-title":"Am J Cardiol"},{"issue":"1","key":"513_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr 28(1):1\u201339 e14","journal-title":"J Am Soc Echocardiogr"},{"issue":"4","key":"513_CR13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","volume":"29","author":"SF Nagueh","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, Flachskampf FA, Gillebert TC, Klein AL, Lancellotti P, Marino P, Oh JK, Popescu BA, Waggoner AD (2016) Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29(4):277\u2013314","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"513_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2008.11.029","volume":"22","author":"H Baumgartner","year":"2009","unstructured":"Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Quinones M (2009) Echocardiographic assessment of valve stenosis: EAE\/ASE recommendations for clinical practice. J Am Soc Echocardiogr 22(1):1\u201323","journal-title":"J Am Soc Echocardiogr"},{"issue":"27","key":"513_CR15","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonz\u00e1lez-Juanatey JR, Harjola V-P, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC) developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J 37(27):2129\u20132200. https:\/\/doi.org\/10.1093\/eurheartj\/ehw128","journal-title":"Eur Heart J"},{"issue":"7","key":"513_CR16","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1056\/NEJMra1710575","volume":"379","author":"BJ Maron","year":"2018","unstructured":"Maron BJ (2018) Clinical course and management of hypertrophic cardiomyopathy. N Engl J Med 379(7):655\u2013668","journal-title":"N Engl J Med"},{"issue":"24","key":"513_CR17","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1136\/heartjnl-2013-303939","volume":"99","author":"LR Lopes","year":"2013","unstructured":"Lopes LR, Rahman MS, Elliott PM (2013) A systematic review and meta-analysis of genotype-phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations. Heart 99(24):1800\u20131811","journal-title":"Heart"},{"issue":"7","key":"513_CR18","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","volume":"121","author":"AJ Marian","year":"2017","unstructured":"Marian AJ, Braunwald E (2017) Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res 121(7):749\u2013770","journal-title":"Circ Res"},{"issue":"2","key":"513_CR19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1161\/CIRCGENETICS.111.960831","volume":"5","author":"SP Page","year":"2012","unstructured":"Page SP, Kounas S, Syrris P, Christiansen M, Frank-Hansen R, Andersen PS, Elliott PM, McKenna WJ (2012) Cardiac myosin binding protein-C mutations in families with hypertrophic cardiomyopathy: disease expression in relation to age, gender, and long term outcome. Circ Cardiovasc Genet 5(2):156\u2013166","journal-title":"Circ Cardiovasc Genet"},{"issue":"1","key":"513_CR20","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/s41598-018-19372-4","volume":"8","author":"J Wang","year":"2018","unstructured":"Wang J, Wan K, Sun J, Li W, Liu H, Han Y, Chen Y (2018) Phenotypic diversity identified by cardiac magnetic resonance in a large hypertrophic cardiomyopathy family with a single MYH7 mutation. Sci Rep 8(1):973","journal-title":"Sci Rep"},{"issue":"1","key":"513_CR21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/0002-8703(87)90017-2","volume":"113","author":"TL Cogswell","year":"1987","unstructured":"Cogswell TL, Sagar KB, Wann LS (1987) Left ventricular ejection dynamics in hypertrophic cardiomyopathy and aortic stenosis: comparison with the use of Doppler echocardiography. Am Heart J 113(1):110\u2013116","journal-title":"Am Heart J"}],"container-title":["Journal of Ultrasound"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40477-020-00513-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40477-020-00513-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40477-020-00513-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T14:32:42Z","timestamp":1628865162000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40477-020-00513-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,25]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["513"],"URL":"https:\/\/doi.org\/10.1007\/s40477-020-00513-3","relation":{},"ISSN":["1876-7931"],"issn-type":[{"type":"electronic","value":"1876-7931"}],"subject":[],"published":{"date-parts":[[2020,7,25]]},"assertion":[{"value":"6 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approved by the local institutional review board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients have written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and for publication"}},{"value":"Available upon request.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}